Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting

NCT05145803 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3300

Last updated 2021-12-20

No results posted yet for this study

Summary

The overall aim of this study is to measure how transmission of COVID-19 occurs in communities - including the role of super spreaders and/or identifying conditions that may increase transmission risk, with a focus on congregant situations. In order to identify how presence of symptoms and behavior affects the transmissibility of the virus, the investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using polyvinyl alcohol (PVA) test strips embedded in face masks (Face Mask Sampling- "FMS") - an innovative, non-invasive method for detection of SARS-CoV-2 in exhaled air.

Conditions

Interventions

DEVICE

Polyvinylalcohol strip [diagnostic]

The investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using PVA test strips embedded in face masks (FMS) - an innovative, non-invasive method for detection of SARS-CoV-2 in exhaled air. Utilizing this approach, the study aims to utilize the test results extracted from the masks to identify risk factors for SARS-CoV-2 transmission and timing of infectious period in exposed people (pre-symptomatic, asymptomatic, and symptomatic).

Sponsors & Collaborators

  • Colorado State University

    collaborator OTHER
  • University of Colorado, Boulder

    collaborator OTHER
  • Colorado Mesa University

    collaborator OTHER
  • Regis University

    collaborator OTHER
  • Denver Health Medical Center

    collaborator OTHER
  • University of Colorado, Colorado Springs

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Colorado School of Public Health

    lead OTHER

Principal Investigators

  • Geoffrey Winstanley, PharmD · Colorado School of Public Health

  • Molly Lamb, PhD · Colorado School of Public Health

  • May Chu, PhD · Colorado School of Public Health

  • Thomas Jaenisch, MD, PhD · Colorado School of Public Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2022-03-09
Completion
2022-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05145803 on ClinicalTrials.gov